S&P 500   4,356.45 (-1.22%)
DOW   34,297.73 (-0.19%)
QQQ   345.11 (-2.32%)
AAPL   159.78 (-1.14%)
MSFT   288.49 (-2.66%)
FB   300.15 (-2.77%)
GOOGL   2,538.70 (-2.96%)
AMZN   2,799.72 (-3.15%)
TSLA   918.40 (-1.25%)
NVDA   223.24 (-4.48%)
BABA   119.14 (-1.02%)
NIO   23.79 (-4.34%)
AMD   111.13 (-4.63%)
CGC   7.36 (-0.54%)
MU   80.72 (-2.69%)
GE   91.11 (-5.98%)
T   26.48 (+0.53%)
F   19.98 (-2.01%)
DIS   136.51 (-0.69%)
AMC   16.02 (-3.73%)
PFE   52.54 (+1.94%)
ACB   4.21 (-2.55%)
BA   204.10 (-0.05%)
S&P 500   4,356.45 (-1.22%)
DOW   34,297.73 (-0.19%)
QQQ   345.11 (-2.32%)
AAPL   159.78 (-1.14%)
MSFT   288.49 (-2.66%)
FB   300.15 (-2.77%)
GOOGL   2,538.70 (-2.96%)
AMZN   2,799.72 (-3.15%)
TSLA   918.40 (-1.25%)
NVDA   223.24 (-4.48%)
BABA   119.14 (-1.02%)
NIO   23.79 (-4.34%)
AMD   111.13 (-4.63%)
CGC   7.36 (-0.54%)
MU   80.72 (-2.69%)
GE   91.11 (-5.98%)
T   26.48 (+0.53%)
F   19.98 (-2.01%)
DIS   136.51 (-0.69%)
AMC   16.02 (-3.73%)
PFE   52.54 (+1.94%)
ACB   4.21 (-2.55%)
BA   204.10 (-0.05%)
S&P 500   4,356.45 (-1.22%)
DOW   34,297.73 (-0.19%)
QQQ   345.11 (-2.32%)
AAPL   159.78 (-1.14%)
MSFT   288.49 (-2.66%)
FB   300.15 (-2.77%)
GOOGL   2,538.70 (-2.96%)
AMZN   2,799.72 (-3.15%)
TSLA   918.40 (-1.25%)
NVDA   223.24 (-4.48%)
BABA   119.14 (-1.02%)
NIO   23.79 (-4.34%)
AMD   111.13 (-4.63%)
CGC   7.36 (-0.54%)
MU   80.72 (-2.69%)
GE   91.11 (-5.98%)
T   26.48 (+0.53%)
F   19.98 (-2.01%)
DIS   136.51 (-0.69%)
AMC   16.02 (-3.73%)
PFE   52.54 (+1.94%)
ACB   4.21 (-2.55%)
BA   204.10 (-0.05%)
S&P 500   4,356.45 (-1.22%)
DOW   34,297.73 (-0.19%)
QQQ   345.11 (-2.32%)
AAPL   159.78 (-1.14%)
MSFT   288.49 (-2.66%)
FB   300.15 (-2.77%)
GOOGL   2,538.70 (-2.96%)
AMZN   2,799.72 (-3.15%)
TSLA   918.40 (-1.25%)
NVDA   223.24 (-4.48%)
BABA   119.14 (-1.02%)
NIO   23.79 (-4.34%)
AMD   111.13 (-4.63%)
CGC   7.36 (-0.54%)
MU   80.72 (-2.69%)
GE   91.11 (-5.98%)
T   26.48 (+0.53%)
F   19.98 (-2.01%)
DIS   136.51 (-0.69%)
AMC   16.02 (-3.73%)
PFE   52.54 (+1.94%)
ACB   4.21 (-2.55%)
BA   204.10 (-0.05%)
NASDAQ:ANIX

Anixa Biosciences Insider Trades

$3.07
+0.05 (+1.66%)
(As of 01/25/2022 12:00 AM ET)
Add
Compare
Today's Range
$2.95
$3.15
50-Day Range
$2.78
$4.42
52-Week Range
$2.71
$8.09
Volume
88,192 shs
Average Volume
122,820 shs
Market Capitalization
$92.51 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.65

Anixa Biosciences (NASDAQ:ANIX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
19.80%

Number Of
Insiders Buying
(Last 12 Months)
4

Amount Of
Insider Buying
(Last 12 Months)
$641.78 K

Number Of
Insiders Selling
(Last 12 Months)
0

Skip Chart & View Insider Trade History

Insider Buying and Selling by Quarter

Get ANIX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Anixa Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.


Anixa Biosciences (NASDAQ ANIX) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/11/2022Lewis H Titterton JrDirectorBuy2,000$3.20$6,400.00  
1/7/2022Amit KumarCEOBuy20,000$3.00$60,000.00  
1/7/2022Lewis H Titterton JrDirectorBuy11,000$3.08$33,880.00  
10/29/2021Amit KumarCEOBuy2,000$4.77$9,540.00  
10/29/2021Lewis H Titterton JrDirectorBuy18,244$4.76$86,841.44  
7/26/2021Lewis H Titterton JrDirectorBuy30,000$4.21$126,300.00935,826  
7/23/2021Amit KumarCEOBuy5,000$4.28$21,400.00292,000  
7/23/2021Arnold M BaskiesDirectorBuy19,000$4.33$82,270.00  
7/16/2021Lewis H Titterton JrDirectorBuy10,000$4.07$40,700.00  
4/23/2021Emily GottschalkDirectorBuy10,000$4.49$44,900.00
4/19/2021Lewis H Titterton JrDirectorBuy5,000$3.99$19,950.00870,326  
3/25/2021Amit KumarCEOBuy5,000$4.86$24,300.00277,000  
3/25/2021Arnold M BaskiesDirectorBuy10,000$4.80$48,000.0015,600  
1/29/2021Amit KumarCEOBuy10,000$3.73$37,300.00272,000  
9/11/2020Amit KumarCEOBuy28,000$2.11$59,080.00262,000  
9/11/2020Lewis H Titterton JrDirectorBuy40,000$2.08$83,200.001,020,326  
6/15/2020Lewis H Titterton JrDirectorBuy31,083$2.35$73,045.05955,826  
6/12/2020Amit KumarCEOBuy20,000$2.03$40,600.00234,000  
3/13/2020Lewis H Titterton JrDirectorBuy5,799$2.12$12,293.88924,743  
1/17/2020Arnold M BaskiesDirectorBuy10,000$3.74$37,400.0021,000  
1/14/2020Amit KumarCEOBuy20,000$2.99$59,800.00194,000  
1/14/2020Lewis H Titterton JrDirectorBuy7,400$3.30$24,420.00913,944  
9/13/2019Amit KumarCEOBuy10,000$4.12$41,200.00
9/13/2019Lewis H Titterton JrDirectorBuy15,000$4.10$61,500.00
4/29/2019John J MonahanDirectorBuy900$4.22$3,798.00  
4/26/2019Amit KumarCEOBuy4,000$4.21$16,840.00  
4/26/2019Arnold M BaskiesDirectorBuy10,000$4.28$42,800.00  
4/24/2019Amit KumarCEOBuy10,000$4.27$42,700.00  
4/22/2019Christopher J SchaberCEOBuy5,000$0.72$3,600.0042,325  
4/22/2019Lewis H Titterton JrDirectorBuy50,000$4.09$204,500.00  
10/25/2018Amit KumarCEOBuy11,000$3.90$42,900.00  
10/25/2018Lewis H Titterton JrDirectorBuy2,000$4.05$8,100.00  
(Data available from 1/1/2013 forward)












Anixa Biosciences (NASDAQ:ANIX) Insider Trade Frequently Asked Questions

Who is on Anixa Biosciences's Insider Roster?

The list of insiders at Anixa Biosciences includes Amit Kumar, Arnold M Baskies, Christopher J Schaber, Emily Gottschalk, John J Monahan, and Lewis H Titterton Jr.Learn more on ANIX's insiders

What percentage of Anixa Biosciences stock is owned by insiders?

19.80% of Anixa Biosciences stock is owned by insiders. Learn more on ANIX's insider holdings

Which Anixa Biosciences insiders have been buying company stock?

The following insiders have purchased Anixa Biosciences stock in the last 24 months: Amit Kumar ($252,220.00), Arnold M Baskies ($130,270.00), Emily Gottschalk ($44,900.00), and Lewis H Titterton Jr ($482,610.37).

How much insider buying is happening at Anixa Biosciences?

Insiders have purchased a total of 282,126 Anixa Biosciences shares in the last 24 months for a total of $910,000.37 bought.

This page was last updated on 1/25/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.